公司资料
Zimmer Biomet 股价、新闻与催化剂
- 股票代码:
- ZBH
- 交易所:
- NYSE
- 行业:
- MedTech
- 所在地:
- United States
股票表现
88.06 USD (-0.87%)
收盘价
最后更新: 2026年10月1日
16.2B USD
市值
股价为何变动
截至 2026年10月1日，ZBH 下跌 0.87%，收于 $88.06。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Musculoskeletal Medical Technology Company
Zimmer Biomet develops implants, instruments, robotics, and digital technologies used to restore mobility and treat musculoskeletal disease. Its portfolio serves orthopedic surgeons, hospitals, ambulatory surgery centers, and patients across joint reconstruction and related procedures.
Knee and Hip Reconstruction
The company's largest franchises include knee and hip implants, revision systems, and enabling instruments. These products address primary and complex joint replacement and are supported by surgeon training, procedure planning, and a large field organization.
S.E.T. and Other Orthopedic Solutions
The S.E.T. portfolio spans sports medicine, extremities, trauma, craniomaxillofacial, and thoracic products. This broadens Zimmer Biomet beyond large joints and provides access to faster-growing procedure categories.
ROSA Robotic Surgery Platform
ROSA systems support robotic assistance in knee, hip, and shoulder procedures. The platform combines preoperative planning, intraoperative data, and surgical execution and creates opportunities for software, service, and implant pull-through.
Digital Care and Data Strategy
Zimmer Biomet integrates connected devices, data analytics, artificial intelligence, and remote-care tools around orthopedic episodes. These technologies are intended to improve surgical planning, patient engagement, recovery monitoring, and operating-room efficiency.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。